Monday, November 9, 2015: 2:15 PM
255B (Salt Palace Convention Center)
Monoclonal antibodies (mAbs) are a class of proteins that represent the largest single group of protein drugs produced by the pharmaceutical and biotechnology industries; annual sales of mAbs now exceed $100 billion. All mAbs share extensive common structural features, but very small local changes in structure, including substitution of a small number (1-3) of amino acids, can lead to dramatic changes in thermodynamic and transport properties. This presentation will cover examples of such changes via a variety of different measurements, with a special focus on the effects of small structural changes. These include effects on mAb self-interactions, oligomerization, phase behavior, and viscosity. Potential molecular bases for this sensitivity will be examined.
See more of this Session: In Honor of Stanley Sandler II
See more of this Group/Topical: Computational Molecular Science and Engineering Forum
See more of this Group/Topical: Computational Molecular Science and Engineering Forum